Free Trial

Alzamend Neuro (ALZN) SEC Filings & 10K Form

Alzamend Neuro logo
$3.57 +0.05 (+1.53%)
As of 02:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Alzamend Neuro SEC Filings

DateFilerForm TypeView
05/09/2025
6:49 PM
Alzamend Neuro (Subject)
Hyperscale Data, Inc. (Reporting)
Hyperscale Data, Inc. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
11:15 PM
Alzamend Neuro (Filer)
Form EFFECT
04/09/2025
5:06 AM
Alzamend Neuro (Filer)
Form 424B3
03/27/2025
3:30 PM
Alzamend Neuro (Filer)
Form S-1/A
03/27/2025
6:30 AM
Alzamend Neuro (Issuer)
Horne William B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
6:30 AM
Alzamend Neuro (Issuer)
Katzoff David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:30 PM
Alzamend Neuro (Issuer)
Horne William B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:00 PM
Alzamend Neuro (Filer)
Form DEFA14A
03/19/2025
3:30 PM
Alzamend Neuro (Issuer)
Horne William B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:12 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:30 PM
Alzamend Neuro (Filer)
Form DEFA14A
03/14/2025
4:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/03/2025
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
3:45 PM
Alzamend Neuro (Filer)
Form PRE 14A
12/12/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
5:01 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:20 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:30 PM
Alzamend Neuro (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/30/2024
5:00 AM
Alzamend Neuro (Filer)
Form NT 10-K
07/12/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
7:52 AM
Alzamend Neuro (Filer)
Form 424B3
07/09/2024
11:15 PM
Alzamend Neuro (Filer)
Form EFFECT
07/08/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
3:31 PM
Alzamend Neuro (Filer)
Form S-1/A
06/26/2024
3:46 PM
Alzamend Neuro (Filer)
Form S-1/A
06/11/2024
3:30 PM
Alzamend Neuro (Filer)
Form DEFA14A
06/03/2024
3:30 PM
Alzamend Neuro (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/22/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALZN) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners